Table 1.xls (9.5 kB)
Characteristics of the patients at randomization.
dataset
posted on 2022-10-10, 17:55 authored by Steve M. Taylor, Sarah Korwa, Angie Wu, Cynthia L. Green, Betsy Freedman, Sheila Clapp, Joseph Kipkoech Kirui, Wendy P. O’Meara, Festus M. NjugunaCharacteristics of the patients at randomization.
History
Usage metrics
Categories
Keywords
sickle cell anemiasecondary outcomes includedreach statistical significancenegative binomial modelsmay limit generalizabilityenhanced supportive careamong secondary outcomesunexpectedly limited transmissionmain secondary outcomelabel trial conducted6 ± 2limited malaria transmissionendemic malaria transmissionserious adverse eventsreduce clinical malariaxlink "> childrenstudy limitations includeprimary analytic populationyoung kenyan childrenplasmodium falciparum chemoprevention regimens varydaily proguanil groupclinical malaria incidencedaily proguanil (<ci ]: 0monthly dp (<clinical malariaprimary outcomedaily proguaniltransmission settingskenyan childrenfalciparum malaria chemopreventiontrial participantstreated populationprevention regimens2 ),painful eventsgeneral eventsaq groupn dp (<246 childrenmonthly sulfadoxinemonthly dpfollowed monthlystudy settingsignificantly differentpragmatic studiesper patientmean ageincidence rateshomozygous hemoglobinhoma bayhigh usehazard ratiodecember 15cumulative incidenceconfidence intervalcomparative efficacyci 0although compared83 ),82 ).12 months10 years038 ).002 ).
